Short-term safety assessment of clobetasol propionate 0.05% shampoo: hypothalamic-pituitary-adrenal axis suppression, atrophogenicity, and ocular safety in subjects with scalp psoriasis.
Year: 2006
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: PubMed
Authors: Philippe Andres, Michel Poncet, Sidou Farzaneh, Pascale Soto
Institution: Galderma (France)
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W190640570
